Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 9, 2009 - Issue 7
Submit an article Journal homepage
223
Views
58
CrossRef citations to date
0
Altmetric
Review

The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer’s disease

Werner J Geldenhuys Department of Pharmaceutical Sciences, Northeastern Ohio Universities Colleges of Medicine and Pharmacy, 4209 State Route 44, Rootstown, OH 44272, USA. [email protected]
&
Cornelis J Van der Schyf Department of Pharmaceutical Sciences, Northeastern Ohio Universities Colleges of Medicine and Pharmacy, 4209 State Route 44, Rootstown, OH 44272, USA. [email protected]
Pages 1073-1085 | Published online: 09 Jan 2014

Citations (58)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Radoslaw Magierski & Tomasz Sobow. (2016) Serotonergic drugs for the treatment of neuropsychiatric symptoms in dementia. Expert Review of Neurotherapeutics 16:4, pages 375-387.
Read now
Martin Broadstock, Clive Ballard & Anne Corbett. (2014) Latest treatment options for Alzheimer’s disease, Parkinson’s disease dementia and dementia with Lewy bodies. Expert Opinion on Pharmacotherapy 15:13, pages 1797-1810.
Read now
Alexandre V Ivachtchenko & Yan A Ivanenkov. (2012) 5HT6 receptor antagonists: a patent update. Part 1. Sulfonyl derivatives. Expert Opinion on Therapeutic Patents 22:8, pages 917-964.
Read now
Ramakrishna V.S. Nirogia, Ramasastri Kambhampati, Anand V. Daulatabad, Parandhama Gudla, Mohammad Shaikh, Pramod Kumar Achanta, Anil K. Shinde & Pramod Kumar Dubey. (2011) Design, synthesis and pharmacological evaluation of conformationally restricted N-arylsulfonyl-3-aminoalkoxy indoles as a potential 5-HT6 receptor ligands. Journal of Enzyme Inhibition and Medicinal Chemistry 26:3, pages 341-349.
Read now
Altaf S Darvesh, Richard T Carroll, Werner J Geldenhuys, Gary A Gudelsky, Jochen Klein, Charles K Meshul & Cornelis J Van der Schyf. (2011) In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery. Expert Opinion on Drug Discovery 6:2, pages 109-127.
Read now
Alexandre V Ivachtchenko, Yan A Ivanenkov & Sergey E Tkachenko. (2010) 5-hydroxytryptamine subtype 6 receptor modulators: a patent survey. Expert Opinion on Therapeutic Patents 20:9, pages 1171-1196.
Read now

Articles from other publishers (52)

Gwenn S. Smith, Hillary Protas, Hiroto Kuwabara, Alena Savonenko, Najlla Nassery, Neda F. Gould, Michael Kraut, Dimitri Avramopoulos, Daniel Holt, Robert F. Dannals, Ayon Nandi, Yi Su, Eric M. Reiman & Kewei Chen. (2023) Molecular imaging of the association between serotonin degeneration and beta-amyloid deposition in mild cognitive impairment. NeuroImage: Clinical 37, pages 103322.
Crossref
Charlotte Uldahl Jansen & Katrine M. Qvortrup. 2022. Serotonin and the CNS - New Developments in Pharmacology and Therapeutics. Serotonin and the CNS - New Developments in Pharmacology and Therapeutics.
Gwenn S. Smith, Clifford I. Workman, Hillary Protas, Yi Su, Alena Savonenko, Hiroto Kuwabara, Neda F. Gould, Michael Kraut, Jin Hui Joo, Ayon Nandi, Dimitri Avramopoulos, Eric M. Reiman & Kewei Chen. (2021) Positron emission tomography imaging of serotonin degeneration and beta-amyloid deposition in late-life depression evaluated with multi-modal partial least squares. Translational Psychiatry 11:1.
Crossref
Marcin Drop, Vittorio Canale, Séverine Chaumont-Dubel, Rafał Kurczab, Grzegorz Satała, Xavier Bantreil, Maria Walczak, Paulina Koczurkiewicz-Adamczyk, Gniewomir Latacz, Anna Gwizdak, Martyna Krawczyk, Joanna Gołębiowska, Katarzyna Grychowska, Andrzej J. Bojarski, Agnieszka Nikiforuk, Gilles Subra, Jean Martinez, Maciej Pawłowski, Piotr Popik, Philippe Marin, Frédéric Lamaty & Paweł Zajdel. (2021) 2-Phenyl-1 H -pyrrole-3-carboxamide as a New Scaffold for Developing 5-HT 6 Receptor Inverse Agonists with Cognition-Enhancing Activity . ACS Chemical Neuroscience 12:7, pages 1228-1240.
Crossref
Philippe De Deurwaerdère, Abdeslam Chagraoui & Giuseppe Di Giovanni. 2021. 5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance - Part B. 5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance - Part B 161 264 .
Mehmet Bostancıklıoğlu. (2019) Optogenetic stimulation of serotonin nuclei retrieve the lost memory in Alzheimer's disease. Journal of Cellular Physiology 235:2, pages 836-847.
Crossref
Jakub Staroń, Rafał Kurczab, Dawid Warszycki, Grzegorz Satała, Martyna Krawczyk, Ryszard Bugno, Tomasz Lenda, Piotr Popik, Adam S. Hogendorf, Agata Hogendorf, Krzysztof Dubiel, Mikołaj Matłoka, Rafał Moszczyński-Pętkowski, Jerzy Pieczykolan, Maciej Wieczorek, Paweł Zajdel & Andrzej J. Bojarski. (2020) Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive properties. European Journal of Medicinal Chemistry 185, pages 111857.
Crossref
Pedro Merino. 2019. Chemical Biology of Neurodegeneration. Chemical Biology of Neurodegeneration 81 120 .
Jeffrey S. KrukSandra BermeoKristen K. SkarrattStephen J. FullerGustavo Duque. (2018) The Effect of Antidepressants on Mesenchymal Stem Cell Differentiation. Journal of Bone Metabolism 25:1, pages 43.
Crossref
Qian-Qian Ouyang, Shannon Zhao, Si-Dong Li & Cai Song. (2017) Application of Chitosan, Chitooligosaccharide, and Their Derivatives in the Treatment of Alzheimer’s Disease. Marine Drugs 15:11, pages 322.
Crossref
Xiaohang Li, Qinying Wang, Tingting Hu, Ying Wang, Jian Zhao, Jing Lu & Gang Pei. (2017) A tricyclic antidepressant, amoxapine, reduces amyloid-β generation through multiple serotonin receptor 6-mediated targets. Scientific Reports 7:1.
Crossref
Alexandre V. Ivachtchenko, Ilya Okun, Vladimir Aladinskiy, Yan Ivanenkov, Angela Koryakova, Ruben Karapetyan, Oleg Mitkin, Ramiz Salimov & Andrey Ivashchenko. (2017) AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation. Journal of Alzheimer's Disease 58:4, pages 1043-1063.
Crossref
Philippe De Deurwaerdère & Giuseppe Di Giovanni. (2017) Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications. Progress in Neurobiology 151, pages 175-236.
Crossref
Kun Cheng Liu, Jun Yi Li, Wen Xie, Li Bo Li, Jin Zhang, Cheng Xue Du, Yu Ming Zhang, Hui Hui Tan, Hui Sheng Wang & Li Zhang. (2016) Activation and blockade of serotonin6 receptors in the dorsal hippocampus enhance T maze and hole-board performance in a unilateral 6-hydroxydopamine rat model of Parkinson's disease. Brain Research 1650, pages 184-195.
Crossref
N.M.W.J. de Bruin, A. van Loevezijn, K.M. Wicke, M. de Haan, J. Venhorst, J.H.M. Lange, L. de Groote, M.A.W. van der Neut, J. Prickaerts, E. Andriambeloson, A.G. Foley, M. van Drimmelen, M. van der Wetering & C.G. Kruse. (2016) The selective 5-HT 6 receptor antagonist SLV has putative cognitive- and social interaction enhancing properties in rodent models of cognitive impairment. Neurobiology of Learning and Memory 133, pages 100-117.
Crossref
Po-Heng Tsai & Jeffrey L. Cummings. 2016. The Behavioral Neurology of Dementia. The Behavioral Neurology of Dementia 415 424 .
V.S. Velingkar, A.K. Chindhe, Mrunal Sanaye & Madhumangiri Gatane. (2016) Design, Synthesis and Evaluation of Substituted 3-(1, 4-Diazepanyl)-Methyl-Phenyl-Sulphonamides as Potent 5-HT6 Antagonists in Cognitive Disorders. Open Pharmaceutical Sciences Journal 3:1, pages 138-148.
Crossref
Alexandre V. Ivachtchenko, Yan Lavrovsky & Yan A. Ivanenkov. (2016) AVN-211, Novel and Highly Selective 5-HT 6 Receptor Small Molecule Antagonist, for the Treatment of Alzheimer’s Disease . Molecular Pharmaceutics 13:3, pages 945-963.
Crossref
Nancy C. Baker, Denis Fourches & Alexander Tropsha. (2015) Drug Side Effect Profiles as Molecular Descriptors for Predictive Modeling of Target Bioactivity. Molecular Informatics 34:2-3, pages 160-170.
Crossref
Jakub Staroń, Dawid Warszycki, Justyna Kalinowska-Tłuścik, Grzegorz Satała & Andrzej J. Bojarski. (2015) Rational design of 5-HT 6 R ligands using a bioisosteric strategy: synthesis, biological evaluation and molecular modelling . RSC Advances 5:33, pages 25806-25815.
Crossref
Susanna Tse, Louis Leung, Sangeeta Raje, Mark Seymour, Yoko Shishikura & R. Scott Obach. (2014) Disposition and Metabolic Profiling of [ 14 C]Cerlapirdine Using Accelerator Mass Spectrometry . Drug Metabolism and Disposition 42:12, pages 2023-2032.
Crossref
Bellinda Benhamú, Mar Martín-Fontecha, Henar Vázquez-Villa, Leonardo Pardo & María L. López-Rodríguez. (2014) Serotonin 5-HT 6 Receptor Antagonists for the Treatment of Cognitive Deficiency in Alzheimer’s Disease . Journal of Medicinal Chemistry 57:17, pages 7160-7181.
Crossref
A V Ivachtchenko. (2014) Sulfonyl-containing modulators of serotonin 5-HT 6 receptors and their pharmacophore models . Russian Chemical Reviews 83:5, pages 439-473.
Crossref
Mohammad Seyedabadi, Gohar Fakhfouri, Vahid Ramezani, Shahram Ejtemaei Mehr & Reza Rahimian. (2014) The role of serotonin in memory: interactions with neurotransmitters and downstream signaling. Experimental Brain Research 232:3, pages 723-738.
Crossref
M Kołaczkowski, P Mierzejewski, P Bieńkowski, A Wesołowska & A Newman-Tancredi. (2014) ADN-1184 a monoaminergic ligand with 5-HT 6/7 receptor antagonist activity: pharmacological profile and potential therapeutic utility . British Journal of Pharmacology 171:4, pages 973-984.
Crossref
. 2014. The Role of 5-HT Systems on Memory and Dysfunctional Memory. The Role of 5-HT Systems on Memory and Dysfunctional Memory 67 84 .
Alfredo Meneses. 2014. Identification of Neural Markers Accompanying Memory. Identification of Neural Markers Accompanying Memory 5 45 .
Boon Chin Heng, Dominique Aubel & Martin Fussenegger. (2013) An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases. Biotechnology Advances 31:8, pages 1676-1694.
Crossref
Jeff S. Kruk, Maryam S. Vasefi, John J. Heikkila & Michael A. Beazely. (2013) Reactive Oxygen Species Are Required for 5-HT-Induced Transactivation of Neuronal Platelet-Derived Growth Factor and TrkB Receptors, but Not for ERK1/2 Activation. PLoS ONE 8:9, pages e77027.
Crossref
A. V. Ivachtchenko, E. S. Golovina, M. G. Kadieva, O. D. Mitkin & I. M. Okun. (2013) 5-Ht6 Receptor Antagonists. V. Structure – Activity Relationship of (4-Phenylsulfonyloxazol-5-yl)amines. Pharmaceutical Chemistry Journal 46:11, pages 639-646.
Crossref
Donatella Marazziti, Stefano Baroni, Andrea Pirone, Gino Giannaccini, Laura Betti, Giovanna Testa, Lara Schmid, Lionella Palego, Franco Borsini, Fabio Bordi, Ilaria Piano, Claudia Gargini, Maura Castagna, Mario Catena-DellOsso & Antonio Lucacchini. (2013) Serotonin receptor of type 6 (5-HT6) in human prefrontal cortex and hippocampus post-mortem: An immunohistochemical and immunofluorescence study. Neurochemistry International 62:2, pages 182-188.
Crossref
Jeff S. Kruk, Maryam S. Vasefi, Hui Liu, John J. Heikkila & Michael A. Beazely. (2013) 5-HT1A receptors transactivate the platelet-derived growth factor receptor type beta in neuronal cells. Cellular Signalling 25:1, pages 133-143.
Crossref
Rima Hajjo, Vincent Setola, Bryan L. Roth & Alexander Tropsha. (2012) Chemocentric Informatics Approach to Drug Discovery: Identification and Experimental Validation of Selective Estrogen Receptor Modulators as Ligands of 5-Hydroxytryptamine-6 Receptors and as Potential Cognition Enhancers. Journal of Medicinal Chemistry 55:12, pages 5704-5719.
Crossref
Werner J. Geldenhuys, Altaf S. Darvesh & Dean E. Dluzen. (2012) Dimebon attenuates methamphetamine, but not MPTP, striatal dopamine depletion. Neurochemistry International 60:8, pages 806-808.
Crossref
Donatella Marazziti, Stefano Baroni, Andrea Pirone, Gino Giannaccini, Laura Betti, Lara Schmid, Elena Vatteroni, Lionella Palego, Franco Borsini, Fabio Bordi, Ilaria Piano, Claudia Gargini, Maura Castagna, Mario Catena-Dell’Osso & Antonio Lucacchini. (2012) Distribution of Serotonin Receptor of Type 6 (5-HT6) in Human Brain Post-mortem. A Pharmacology, Autoradiography and Immunohistochemistry Study. Neurochemical Research 37:5, pages 920-927.
Crossref
Louise Witten, Benny Bang-Andersen, Søren Møller Nielsen, Silke Miller, Claus Tornby Christoffersen, Tine Bryan Stensbøl, Lise Tøttrup Brennum & Jørn Arnt. (2012) Characterization of [3H]Lu AE60157 ([3H]8-(4-methylpiperazin-1-yl)-3-phenylsulfonylquinoline) binding to 5-hydroxytryptamine6 (5-HT6) receptors in vivo. European Journal of Pharmacology 676:1-3, pages 6-11.
Crossref
Arnold van Loevezijn, Jennifer Venhorst, Wouter I. Iwema Bakker, Cor G. de Korte, Wouter de Looff, Stefan Verhoog, Jan-Willem van Wees, Martijn van Hoeve, Rob P. van de Woestijne, Martina A. W. van der Neut, Alice J. M. Borst, Maria J. P. van Dongen, Natasja M. W. J. de Bruin, Hiskias G. Keizer & Chris G. Kruse. (2011) N ′-(Arylsulfonyl)pyrazoline-1-carboxamidines as Novel, Neutral 5-Hydroxytryptamine 6 Receptor (5-HT 6 R) Antagonists with Unique Structural Features . Journal of Medicinal Chemistry 54:20, pages 7030-7054.
Crossref
Werner J. Geldenhuys & Cornelis J. Van der Schyf. (2011) Role of Serotonin in Alzheimerʼs Disease. CNS Drugs 25:9, pages 765-781.
Crossref
Clément Menuet, Peter Borghgraef, Valéry Matarazzo, Lies Gielis, Anne-Marie Lajard, Nicolas Voituron, Christian Gestreau, Mathias Dutschmann, Fred Van Leuven & Gérard Hilaire. (2011) Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: Possible implications for tauopathies and Alzheimer's disease. Respiratory Physiology & Neurobiology 178:2, pages 290-303.
Crossref
Ramakrishna Nirogi, Adireddy Dwarampudi, Ramasastry Kambhampati, Venugopalarao Bhatta, Laxman Kota, Anil Shinde, Rajesh Badange, Pradeep Jayarajan, Gopinadh Bhyrapuneni & P.K. Dubey. (2011) Rigidized 1-aryl sulfonyl tryptamines: Synthesis and pharmacological evaluation as 5-HT6 receptor ligands. Bioorganic & Medicinal Chemistry Letters 21:15, pages 4577-4580.
Crossref
Marieke Liem-Moolenaar, Mandana Rad, Stefano Zamuner, Adam F. Cohen, Francesca Lemme, Kari L. Franson, Joop M. A. van Gerven & Emilio Merlo Pich. (2011) Central nervous system effects of the interaction between risperidone (single dose) and the 5-HT6 antagonist SB742457 (repeated doses) in healthy men. British Journal of Clinical Pharmacology 71:6, pages 907-916.
Crossref
Franco Borsini, Fabio Bordi & Teresa Riccioni. (2011) 5-HT6 pharmacology inconsistencies. Pharmacology Biochemistry and Behavior 98:2, pages 169-172.
Crossref
Amantha Thathiah & Bart De Strooper. (2011) The role of G protein-coupled receptors in the pathology of Alzheimer's disease. Nature Reviews Neuroscience 12:2, pages 73-87.
Crossref
Ramakrishna V.S. Nirogi, Amol D. Deshpande, Ramasastri Kambhampati, Rajesh Kumar Badange, Laxman Kota, Anand V. Daulatabad, Anil K. Shinde, Ishtiyaque Ahmad, Vishwottam Kandikere, Pradeep Jayarajan & P.K. Dubey. (2011) Indole-3-piperazinyl derivatives: Novel chemical class of 5-HT6 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 21:1, pages 346-349.
Crossref
Ellen Siobhan Mitchell. 2011. International Review of Neurobiology Volume 96. International Review of Neurobiology Volume 96 163 187 .
Alfredo Meneses, Georgina Pérez-García, T. Ponce-Lopez & Carlos Castillo. 2011. International Review of Neurobiology Volume 96. International Review of Neurobiology Volume 96 27 47 .
Ramakrishna V. S. Nirogi, Prabhakar Kothmirkar, Ramasastri Kambhampati, Jagadish Babu Konda, Sobhanadri Arepalli, Narasimhareddy G. Pamuleti, Amol D. Deshpande, Trinathreddy Bandyala, Anil K. Shinde & P. K. Dubey. (2010) Novel and Potent 5-Piperazinyl Methyl- N 1 -aryl Sulfonyl Indole Derivatives as 5-HT 6 Receptor Ligands . ACS Medicinal Chemistry Letters 1:7, pages 340-344.
Crossref
Ramakrishna V.S. Nirogi, Anand V. Daulatabad, G. Parandhama, Shaikh Mohammad, K.R. Sastri, Anil K. Shinde & P.K. Dubey. (2010) Synthesis and pharmacological evaluation of aryl aminosulfonamide derivatives as potent 5-HT6 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 20:15, pages 4440-4443.
Crossref
Angelo Mancinelli. 2010. Pharmacology of 5-HT6 receptors - Part 1. Pharmacology of 5-HT6 receptors - Part 1 153 172 .
Massimo Gennarelli & Annamaria Cattaneo. 2010. Pharmacology of 5-HT6 receptors - Part 1. Pharmacology of 5-HT6 receptors - Part 1 129 151 .
Annalisa Tassone, Graziella Madeo, Giuseppe Sciamanna, Antonio Pisani & Paola Bonsi. 2010. Pharmacology of 5-HT6 receptors - Part 1. Pharmacology of 5-HT6 receptors - Part 1 111 128 .
Małgorzata Filip & Michael Bader. (2009) Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system. Pharmacological Reports 61:5, pages 761-777.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.